Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Microbot Medical Inc. - Common Stock (NQ:MBOT)

1.787 +0.017 (+0.98%)
Streaming Delayed Price Updated: 1:30 PM EDT, Jun 26, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 282,020
Open 1.760
Bid (Size) 1.780 (3,200)
Ask (Size) 1.790 (5,000)
Prev. Close 1.770
Today's Range 1.755 - 1.810
52wk Range 1.600 - 4.670
Shares Outstanding 67,158,044
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Microbot Medical® Wins Surgical Robotics Industry Award for the LIBERTY® Endovascular Robotic System
Innovative Start-Up award recognizes LIBERTY as a highly innovative, ground-breaking product with potentially wide range and/or substantial benefit 
From Microbot Medical Inc.
Via GlobeNewswire
News headline image
Microbot Medical® Announces First Health System in Pennsylvania to Adopt the LIBERTY® Endovascular Robotic System
From Microbot Medical Inc.
Via GlobeNewswire

Performance

YTD
-15.3%
-15.3%
1 Month
-1.3%
-1.3%
3 Month
-31.8%
-31.8%
6 Month
-16.9%
-16.9%
1 Year
-27.0%
-27.0%

More News

Read More
News headline image
Microbot Medical® Enters Into an Agreement to Expand Access for America’s Veteran and Military Patient Populations
From Microbot Medical Inc.
Via GlobeNewswire
News headline image
Microbot Medical® Announces a Notable Health System as the First in Michigan to Adopt the LIBERTY® Endovascular Robotic System
From Microbot Medical Inc.
Via GlobeNewswire
News headline image
Microbot Medical® Secures the First Healthcare System in North Carolina to Adopt the LIBERTY® Endovascular Robotic System
From Microbot Medical Inc.
Via GlobeNewswire
News headline image
Microbot Medical® Receives Its First International Regulatory Approval for the Commercialization of the LIBERTY® Endovascular Robotic System
From Microbot Medical Inc.
Via GlobeNewswire
News headline image
Microbot Medical to Hold Analysts and Investors Conference Call to Review Recent Progress; Executive Team will be Joined by Current Users of the LIBERTY Endovascular Robotic System, Dr. Charles Briggs and Dr. Zachary Bercu
From Microbot Medical Inc.
Via GlobeNewswire
News headline image
Microbot Medical Successfully Transitions to Commercial Operations as It Records Revenue Resulting from Its Limited Market Release During the First Quarter of 2026
From Microbot Medical Inc.
Via GlobeNewswire
News headline image
Microbot Medical®’s LIBERTY® Endovascular Robotic System is Now Adopted by Multiple Accounts Across Key Territories Including Two ACCESS-PVI Pivotal Clinical Trial Sites
From Microbot Medical Inc.
Via GlobeNewswire
News headline image
Microbot Medical® Announces the Addition of Senior Commercial Executive with Proven Track Record to Accelerate Commercial Readiness in Europe, the Middle East, and Asia (EMEA)
From Microbot Medical Inc.
Via GlobeNewswire
News headline image
Microbot Medical® Welcomes Updated Occupational Protection Guidelines from Leading Medical Societies, Strengthening Commercial Position of LIBERTY®
From Microbot Medical Inc.
Via GlobeNewswire
News headline image
Microbot Medical® to Highlight Commercial Achievements Leading to the Full Market Release (FMR) of the LIBERTY® Endovascular Robotic System at the 25th Annual Needham Virtual Healthcare Conference
From Microbot Medical Inc.
Via GlobeNewswire
News headline image
Microbot Medical® Commences Full Market Release (FMR) of the LIBERTY® Endovascular Robotic System in the U.S. at the Society of Interventional Radiology (SIR) Annual Scientific Meeting
From Microbot Medical Inc.
Via GlobeNewswire
News headline image
Emory Healthcare Successfully Completes Robotic Peripheral Endovascular Procedures using Microbot Medical®’s LIBERTY® Endovascular Robotic System
From Microbot Medical Inc.
Via GlobeNewswire
News headline image
Microbot Medical® Strengthens LIBERTY® Endovascular Robotic System Position with Publication of its ACCESS PVI Pivotal Study in Leading Peer-Reviewed Medical Journal
From Microbot Medical Inc.
Via GlobeNewswire
News headline image
Microbot Medical® to Participate at the 38th Annual Roth Conference
From Microbot Medical Inc.
Via GlobeNewswire
News headline image
Microbot Medical® to Participate at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference for The First Time
From Microbot Medical Inc.
Via GlobeNewswire
News headline image
Microbot Medical® Aligns with Recently Adopted Policy of the Largest U.S.-Based Medical Association to Expand Protection for Healthcare Professionals from Ionizing Radiation
From Microbot Medical Inc.
Via GlobeNewswire
News headline image
MBOT Stock Falls As Investors Ponder Impact Of Geopolitical Tensions On Israel-Founded Company ↗
Via Stocktwits
News headline image
Microbot Medical® Confirms Continued Operational and Commercial Stability Amid Current Geopolitical Event
From Microbot Medical Inc.
Via GlobeNewswire
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
Via Chartmill
News headline image
Tampa General Hospital is the First Health System in Florida to Adopt the LIBERTY® Endovascular Robotic System
From Microbot Medical Inc.
Via GlobeNewswire
News headline image
Microbot Medical®’s LIBERTY® Endovascular Robotic System Continues to Expand Market Visibility; Being Featured at an Industry Leading Innovation Conference
From Microbot Medical Inc.
Via GlobeNewswire
News headline image
Microbot Medical®’s LIBERTY® Endovascular Robotic System Highlighted at a Leading Vascular Disease Management Conference
From Microbot Medical Inc.
Via GlobeNewswire
News headline image
Microbot Medical® to Leverage Current Users Experience of the LIBERTY® Endovascular Robotic System at Key Oncology Conference to Support Commercial Adoption
From Microbot Medical Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Microbot Medical Inc. - Common Stock publicly traded?
Yes, Microbot Medical Inc. - Common Stock is publicly traded.
What exchange does Microbot Medical Inc. - Common Stock trade on?
Microbot Medical Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Microbot Medical Inc. - Common Stock?
The ticker symbol for Microbot Medical Inc. - Common Stock is MBOT on the Nasdaq Stock Market
What is the current price of Microbot Medical Inc. - Common Stock?
The current price of Microbot Medical Inc. - Common Stock is 1.787
When was Microbot Medical Inc. - Common Stock last traded?
The last trade of Microbot Medical Inc. - Common Stock was at 06/26/26 01:30 PM ET
What is the market capitalization of Microbot Medical Inc. - Common Stock?
The market capitalization of Microbot Medical Inc. - Common Stock is 120.03M
How many shares of Microbot Medical Inc. - Common Stock are outstanding?
Microbot Medical Inc. - Common Stock has 120M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.